159 related articles for article (PubMed ID: 12370037)
1. Tubulin as an antiprotozoal drug target.
Werbovetz KA
Mini Rev Med Chem; 2002 Dec; 2(6):519-29. PubMed ID: 12370037
[TBL] [Abstract][Full Text] [Related]
2. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
3. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerases as targets for antiprotozoal therapy.
Bakshi RP; Shapiro TA
Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
[TBL] [Abstract][Full Text] [Related]
5. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
6. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
Darkin-Rattray SJ; Gurnett AM; Myers RW; Dulski PM; Crumley TM; Allocco JJ; Cannova C; Meinke PT; Colletti SL; Bednarek MA; Singh SB; Goetz MA; Dombrowski AW; Polishook JD; Schmatz DM
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13143-7. PubMed ID: 8917558
[TBL] [Abstract][Full Text] [Related]
7. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.
Docampo R; Moreno SN
Curr Pharm Des; 2008; 14(9):882-8. PubMed ID: 18473837
[TBL] [Abstract][Full Text] [Related]
8. Cellular effects of leishmanial tubulin inhibitors on L. donovani.
Havens CG; Bryant N; Asher L; Lamoreaux L; Perfetto S; Brendle JJ; Werbovetz KA
Mol Biochem Parasitol; 2000 Oct; 110(2):223-36. PubMed ID: 11071278
[TBL] [Abstract][Full Text] [Related]
9. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
10. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
11. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
12. Drugs targeting parasite lysosomes.
Doyle PS; Sajid M; O'Brien T; Dubois K; Engel JC; Mackey ZB; Reed S
Curr Pharm Des; 2008; 14(9):889-900. PubMed ID: 18473838
[TBL] [Abstract][Full Text] [Related]
13. The interactions between drugs and the parasite surface.
Chappell LH
Parasitology; 1988; 96 Suppl():S167-93. PubMed ID: 3287289
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthesis in protozoan parasites: unusual pathways and novel drug targets.
Goodman CD; McFadden GI
Curr Pharm Des; 2008; 14(9):901-16. PubMed ID: 18473839
[TBL] [Abstract][Full Text] [Related]
15. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
Reguera RM; Tekwani BL; Balaña-Fouce R
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
Bhattacharya G; Salem MM; Werbovetz KA
Bioorg Med Chem Lett; 2002 Sep; 12(17):2395-8. PubMed ID: 12161141
[TBL] [Abstract][Full Text] [Related]
17. N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis.
Tate EW; Bell AS; Rackham MD; Wright MH
Parasitology; 2014 Jan; 141(1):37-49. PubMed ID: 23611109
[TBL] [Abstract][Full Text] [Related]
18. Genomic databases and the search of protein targets for protozoan parasites.
Timmers LF; Pauli I; Barcellos GB; Rocha KB; Caceres RA; de Azevedo WF; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):240-5. PubMed ID: 19275560
[TBL] [Abstract][Full Text] [Related]
19. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
20. Selective lead compounds against kinetoplastid tubulin.
Morgan RE; Werbovetz KA
Adv Exp Med Biol; 2008; 625():33-47. PubMed ID: 18365657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
